VCYT
Veracyte Inc.
NASDAQ · Healthcare
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — |
| Investing | |||||||||||
| Capital Expenditures | 9.7M | 11.3M | 10.0M | 8.5M | 5.4M | 2.8M | 2.8M | 1.9M | 1.8M | 4.2M | 6.2M |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing | |||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — |
| Summary | |||||||||||
| Free Cash Flow | 126.6M | 63.8M | 34.3M | -1.0M | -37.0M | -12.5M | -6.0M | -15.4M | -25.7M | -32.2M | -33.1M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — |